Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Animal antimicrobial peptides: An overview

Animal antimicrobial peptides: An overview Antibiotic peptides are a key component of the innate immune systems of most multicellular organisms. Despite broad divergences in sequence and taxonomy, most antibiotic peptides share a common mechanism of action, i.e., membrane permeabilization of the pathogen. This review provides a general introduction to the subject, with emphasis on aspects such as structural types, post‐translational modifications, mode of action or mechanisms of resistance. Some of these questions are treated in depth in other reviews in this issue. The review also discusses the role of antimicrobial peptides in nature, including several pathological conditions, as well as recent accounts of their application at the preclinical level. © 1999 John Wiley & Sons, Inc. Biopoly 47: 415–433, 1998 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Biopolymers Wiley

Animal antimicrobial peptides: An overview

Biopolymers , Volume 47 (6) – Jan 1, 1998

Loading next page...
 
/lp/wiley/animal-antimicrobial-peptides-an-overview-JOdZaMJQ5h

References (314)

Publisher
Wiley
Copyright
Copyright © 1998 John Wiley & Sons, Inc.
ISSN
0006-3525
eISSN
1097-0282
DOI
10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
pmid
10333735
Publisher site
See Article on Publisher Site

Abstract

Antibiotic peptides are a key component of the innate immune systems of most multicellular organisms. Despite broad divergences in sequence and taxonomy, most antibiotic peptides share a common mechanism of action, i.e., membrane permeabilization of the pathogen. This review provides a general introduction to the subject, with emphasis on aspects such as structural types, post‐translational modifications, mode of action or mechanisms of resistance. Some of these questions are treated in depth in other reviews in this issue. The review also discusses the role of antimicrobial peptides in nature, including several pathological conditions, as well as recent accounts of their application at the preclinical level. © 1999 John Wiley & Sons, Inc. Biopoly 47: 415–433, 1998

Journal

BiopolymersWiley

Published: Jan 1, 1998

There are no references for this article.